Global Myasthenia Gravis Treatment Market Growth 2025-2031

The global Myasthenia Gravis Treatment market size is predicted to grow from US$ 1971 million in 2025 to US$ 2915 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.

Drug therapy for MG includes: (1) acetylcholinesterase inhibitors, (2) immunosuppressants, (3) immunomodulators. Introduce and gradually increase options based on international guidelines and the clinical and immunological characteristics of patients. Surgical treatments include (1) thymectomy, (2) median sternotomy and video-assisted thoracoscopic surgery, etc.

The major factors driving the market growth are increasing prevalence of myasthenia gravis, awareness for early diagnosis of myasthenia gravis, and adoption of new treatment options for myasthenia gravis. Rising prevalence of myasthenia gravis globally is one of the major drivers for the growth of the myasthenia gravis treatment market. For example, according to the Myasthenia Gravis Foundation of America, about 20 out of every 100,000 people in the United States have myasthenia gravis, and the disease is more common in women than men. Furthermore, the incidence of myasthenia gravis is increasing worldwide.

LP Information, Inc. (LPI) ' newest research report, the “Myasthenia Gravis Treatment Industry Forecast” looks at past sales and reviews total world Myasthenia Gravis Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Myasthenia Gravis Treatment sales for 2025 through 2031. With Myasthenia Gravis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Myasthenia Gravis Treatment industry.

This Insight Report provides a comprehensive analysis of the global Myasthenia Gravis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Myasthenia Gravis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Myasthenia Gravis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Myasthenia Gravis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Myasthenia Gravis Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Myasthenia Gravis Treatment market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Monoclonal Antibodies
Intravenous Immunoglobulin
Other

Segmentation by Application:
Hospital
Specialist Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Amneal Pharmaceuticals, Inc.
Astellas Pharma, Inc.
Avadel Pharmaceuticals PLC
Bausch Health Companies Inc.
CSL Behring
CuraVac, Inc.
Argenx SE
GlaxoSmithKline plc
Immunovant, Inc.
Mitsubishi Tanabe Pharma Corp.
Novartis AG
Takeda Pharmaceutical Co., Ltd.
UCB Pharma
AstraZeneca
F. Hoffmann-La Roche Ltd

Key Questions Addressed in this Report

What is the 10-year outlook for the global Myasthenia Gravis Treatment market?

What factors are driving Myasthenia Gravis Treatment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Myasthenia Gravis Treatment market opportunities vary by end market size?

How does Myasthenia Gravis Treatment break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Myasthenia Gravis Treatment by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Myasthenia Gravis Treatment by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings